Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Potential drug targets for chronic obstructive pulmonary disease in the plasma proteome identified through Mendelian randomization

Submitted by Anna Hakala on Thu, 11/27/2025 - 11:04
  • Read more about Potential drug targets for chronic obstructive pulmonary disease in the plasma proteome identified through Mendelian randomization

Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation

Submitted by Anna Hakala on Thu, 11/27/2025 - 11:03
  • Read more about Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation

Causal relationships of Janus kinase 2 with chronic kidney diseases: a two-sample Mendelian randomisation study

Submitted by Anna Hakala on Thu, 11/27/2025 - 11:02
  • Read more about Causal relationships of Janus kinase 2 with chronic kidney diseases: a two-sample Mendelian randomisation study

CXCL10 promotes non-small cell lung cancer (NSCLC) progression by modulating the phosphate to urate ratio (PUR)

Submitted by Anna Hakala on Thu, 11/27/2025 - 11:01
  • Read more about CXCL10 promotes non-small cell lung cancer (NSCLC) progression by modulating the phosphate to urate ratio (PUR)

Causal Effects Between Retinal Characteristics and Cardiovascular Diseases: Insights from Genetic Correlation, Mendelian Randomization, and Cross-Sectional Study

Submitted by Anna Hakala on Thu, 11/27/2025 - 11:00
  • Read more about Causal Effects Between Retinal Characteristics and Cardiovascular Diseases: Insights from Genetic Correlation, Mendelian Randomization, and Cross-Sectional Study

Causal Effects of Endometriosis Stages on Adverse Pregnancy and Perinatal Outcomes: A Mendelian Randomization Study

Submitted by Anna Hakala on Thu, 11/27/2025 - 10:56
  • Read more about Causal Effects of Endometriosis Stages on Adverse Pregnancy and Perinatal Outcomes: A Mendelian Randomization Study

Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

Submitted by Anna Hakala on Mon, 11/24/2025 - 15:43
  • Read more about Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

The Role of Metabolites in CSF on NAFLD Development: A Mendelian Randomisation Analysis

Submitted by Anna Hakala on Mon, 11/24/2025 - 15:28
  • Read more about The Role of Metabolites in CSF on NAFLD Development: A Mendelian Randomisation Analysis

From Normal Variation in Sleep to Clinical Sleep Disorders: Genetic Insights from Over One Million Individuals

Submitted by Anna Hakala on Mon, 11/24/2025 - 14:58
  • Read more about From Normal Variation in Sleep to Clinical Sleep Disorders: Genetic Insights from Over One Million Individuals

Association of AAT/SERPINA1 PI*Z Variant with Gestational Duration and Prevention of Premature Birth in Knockout Mice by AAT-Supplementation

Submitted by Anna Hakala on Mon, 11/24/2025 - 14:54
  • Read more about Association of AAT/SERPINA1 PI*Z Variant with Gestational Duration and Prevention of Premature Birth in Knockout Mice by AAT-Supplementation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement